Literature DB >> 6274650

Atypical characteristics of frog and chick erythrocyte beta-adrenoceptors.

K E Dickinson, S R Nahorski.   

Abstract

The characteristics of beta-adrenoceptors on frog and chick erythrocytes have been compared to those present on rat erythrocyte, lung and cerebral cortical membranes. The receptors have been examined using the specific ligand [3H]dihydroalprenolol ([3H]DHA) with conventional filtration techniques. The equilibrium dissociation constant (KD) of [3H]DHA and the affinities of the non-selective beta-adrenoceptor antagonists propranolol, timolol and alprenolol, were very similar in all preparations examined. The relative order of potency of the catecholamines, isoprenaline greater than adrenaline greater than noradrenaline in rat lung, rat erythrocyte and frog erythrocyte; isoprenaline greater than noradrenaline greater than or equal to adrenaline in chick erythrocyte and rat cortex, suggest an overall beta 2-classification for the former and beta 1-classification of the latter tissues. However, the use of highly selective beta 1- or beta 2-agents and computer-assisted iterative curve fitting revealed that whereas rat cortex and lung possess both receptor subtypes (lung 80% beta 2, 20% beta 1: cortex 65% beta 1, 35% beta 2) only beta 2-sites were observed in rat erythrocytes. On the other hand, chick and frog erythrocytes possess a homogeneous population of receptors that do not strictly correspond either to beta 1- or beta 2-adrenoceptors. The atypical nature of these non-mammalian erythrocyte beta-adrenoceptors is discussed in relation to their previous extensive use as model beta-adrenoceptor systems.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6274650     DOI: 10.1016/0014-2999(81)90321-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Atypical characteristics of the beta-adrenoceptor mediating cyclic AMP generation and lipolysis in the rat adipocyte.

Authors:  D Bojanic; J D Jansen; S R Nahorski; J Zaagsma
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

Review 2.  Beta-adrenoceptor blocking agents and lipolysis.

Authors:  H H Harms; J De Vente; J Zaagsma
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

3.  Effects of selective phosphodiesterase inhibition on cyclic AMP hydrolysis in rat cerebral cortical slices.

Authors:  R A Challiss; C D Nicholson
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

4.  Responses to the beta 2-selective agonist procaterol of vascular and atrial preparations with different functional beta-adrenoceptor populations.

Authors:  S R O'Donnell; J C Wanstall
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

5.  Human platelet beta 2-adrenoceptors: agonist-induced internalisation and down-regulation in intact cells.

Authors:  N Cook; S R Nahorski; D B Barnett
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

6.  Human myocardial beta-adrenoceptors: demonstration of both beta 1- and beta 2-adrenoceptors mediating contractile responses to beta-agonists on the isolated right atrium.

Authors:  H R Zerkowski; K Ikezono; N Rohm; J C Reidemeister; O E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-02       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.